Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)

Ferreras, C.; Hernández, C.; Martín-Quirós, A.; Al-Akioui-Sanz, K.; Mora-Rillo, M.; Ibáñez, F.; Goterris, R.; de Paz, R.; Guerra-García, P.; Queiruga-Parada, J.; Molina, P.; Briones, M.; Planelles, D.; Borobia, A. M.; Carcas, A.; Vicario, J. L.; Moreno, M.; Balas, A.; Eguizabal, C.; Soria, B.

Ferreras, C.; Hernández, C.; Martín-Quirós, A.; Al-Akioui-Sanz, K.; Mora-Rillo, M.; Ibáñez, F.; Goterris, R.; de Paz, R.; Guerra-García, P.; Queiruga-Parada, J.; Molina, P.; Briones, M.; Planelles, D.; Borobia, A. M.; Carcas, A.; Vicario, J. L.; Moreno, M.; Balas, A.; Eguizabal, C.; Soria, B..

Cytotherapy (Elsevier Inc) ; 25(6):S30-S31, 2023.

Article in English | Academic Search Complete | ID: covidwho-2314512

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Academic Search Complete Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Cytotherapy (Elsevier Inc) Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google